Cell Source, Inc. Proceeds from Issuance or Sale of Equity
Cell Source, Inc. (CLCS) reported Proceeds from Issuance or Sale of Equity of $603.36 thousand for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2020-08-14
- 2020-06-30: Proceeds from Issuance or Sale of Equity 6 month $603.36K.
| Period end | Proceeds from Issuance or Sale of Equity 6 month |
|---|---|
| 2020-06-30 | $603.36K 10-Q · filed 2020-08-14 |